The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $49.76

Today's change+0.49 +0.99%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $49.76

Today's change+0.49 +0.99%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

U.S. Physical Therapy Inc up (U.S.)$0.49

U.S. Physical Therapy Inc closed up Friday by (U.S.)$0.49 or 0.99% to (U.S.)$49.76. Over the last five days, shares have gained 4.80%, but are down 7.30% for the last year to date. Shares have outperformed the S&P 500 by 32.05% during the last year.

Key company metrics

  • Open(U.S.) $49.90
  • Previous close(U.S.) $49.27
  • High(U.S.) $49.98
  • Low(U.S.) $48.40
  • Bid / Ask-- / --
  • YTD % change-7.30%
  • Volume90,332
  • Average volume (10-day)68,057
  • Average volume (1-month)81,312
  • Average volume (3-month)105,491
  • 52-week range(U.S.) $40.07 to (U.S.) $56.37
  • Beta0.98
  • Trailing P/E27.97×
  • P/E 1 year forward28.03×
  • Forward PEG1.87×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield1.21%
  • Trailing EPS(U.S.) $1.78
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.44%

Based on its net profit margin of 9.44%, U.S. Physical Therapy Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue84837779
Total other revenue--------
Total revenue84837779
Gross profit19211719
Total cost of revenue65626060
Total operating expense72706869
Selling / general / administrative7888
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income1214911
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1213911
Income after tax8967
Income tax, total4433
Net income6645
Total adjustments to net income----01
Net income before extra. items6645
Minority interest-2-3-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6646
Inc. avail. to common incl. extra. items6646
Diluted net income6646
Dilution adjustment--0----
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.470.480.340.49
Dividends per sharevalue per share0.150.150.150.12
Diluted normalized EPSvalue per share0.470.480.340.51